arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ORASURE TECHNOLOGIES INC

OSUR
$3.36 ▼ -0.36 (-9.68%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

ORASURE TECHNOLOGIES INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $231.9M
Dividend Yield —
Revenue Growth -1.9% ↗
Op. Margin 17.8% ↗
ROIC 1.4% ↗
FCF / Share $-0.18 ↗
Trailing P/E 37.3x
Price / Book 0.7x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$30.64M
↓ -1.9% —
Net Income Profit after all expenses
$-22.38M
↓ -39.5% —
Operating Margin Operating profit as % of sales
17.8%
↑ +121.3% 4th
FCF / Share Free cash flow per share
$-0.18
↑ +15.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
5
Returns ↓
28
Cash Quality ↓
52

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters